Is the world’s first and only blood based Professional Point of Care test for Vulvovaginal Candidiasis. This CE-marked test utilizes just 2.5 microlitres of whole blood taken from a fingerstick to provide accurate diagnosis within 6 minutes.

The test is indicated as a screening test during pregnancy. This is because women are at high risk of developing VVC during the pregnancy and it is known that VVC during pregnancy is significantly associated with Intrauterine Growth Retardation. Recent evidence has also shown that screening and treatment of VVC during pregnancy may significantly reduce the prevalence of preterm labour.

Between 5% and 10% of healthy women of reproductive age may suffer from recurrent VVC. This is defined in the medical literature as 4 -5 infections per year. Since symptoms of VVC are usually non specific, it is important to ensure that accurate differential diagnosis is performed before embarking on a course of treatment.

CanDia5® is a lateral flow assay which requires five simple steps in order to perform accurate diagnosis. All of the accessories required to perform the test are included within the box.